From intestines to skeleton: The impact of incretin hormones on human bone

Medicine and Dentistry

• Intestine 100%
• Skeleton 100%
• Incretin 100%
• Gastric Inhibitory Polypeptide 100%
• Glucagon Like Peptide 1 83%
• Osteoclast 50%
• Osteoclast Activity 50%
• In Vitro 41%
• Osteolysis 41%
• Osteoblast 41%
• Semaglutide 41%
• Glucagon-Like Peptide-1 Agonist 33%
• Biological Marker 25%
• Receptor 25%
• Osteoclastogenesis 25%
• Food Intake 25%
• Bone Turnover 16%
• Ossification 16%
• RNA Sequence 16%
• G Protein Coupled Receptor 16%
• Glucagon Like Peptide 1 Receptor 16%
• Receptor Expression 8%
• Placebo 8%
• Insulin Release 8%
• Signal Transduction 8%
• Bone Density 8%
• Hip 8%
• Confocal Microscopy 8%
• Cell Activity 8%
• Hormone Receptor 8%
• Bone Tissue 8%
• Mineralization 8%
• Receptor Antagonist 8%
• Polypeptide 8%
• Gastrointestinal Hormone 8%

Immunology and Microbiology

• Agonist 100%
• Osteoclast 100%
• Skeleton 100%
• Osteoclast Activity 100%
• Intestine 100%
• Osteoblast 83%
• Osteolysis 83%
• Osteoclastogenesis 50%
• Blood Level 33%
• Ossification 33%
• Bone Turnover 33%
• RNA Sequence 33%
• Bone Density 16%
• Signal Transduction 16%
• Hip 16%
• Pancreas 16%
• Insulin Release 16%
• Bone Cell 16%
• Bone Tissue 16%
• Cell Activity 16%
• Mineralization 16%
• Adaptation 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Incretin 100%
• Gastric Inhibitory Polypeptide 100%
• Glucagon-Like Peptide-1 83%
• Semaglutide 41%
• Glucagon Like Peptide 1 Receptor Agonist 33%
• Receptor 25%
• Biological Marker 25%
• Glucagon-Like Peptide 1 Receptor 16%
• G Protein Coupled Receptor 16%
• RNA-Sequencing 16%
• Placebo 8%
• Receptor Antagonist 8%
• Polypeptide 8%
• Confocal Microscopy 8%
• Hormone Receptor 8%
• Gastrointestinal Hormone 8%